Recombinant human bone morphogenetic protein-2: A randomized trial in open tibial fractures treated with reamed nail fixation

Journal of Bone and Joint Surgery

Volumn 93, Issue 9, 2011, Pages 801-808

  Aro, Hannu T ^a   Govender, Shunmugam ^b   Patel, Amratlal D ^c   Hernigou, Philippe ^d   De Gregorio, Arturo Perera ^e   Popescu, Gheorghe Ion ^f   Golden, Jane Davis ^g   Christensen, Jared ^g   Valentin, Alexandre ^g  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d HENRI MONDOR HOSPITAL   (France)

^e HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^f Emergency Hospital   (Romania)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; IMPLANT; INFECTION; INFECTION RISK; INJURY SEVERITY; INTENTION TO TREAT ANALYSIS; INTRAMEDULLARY NAILING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OPEN FRACTURE; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SINGLE BLIND PROCEDURE; SOFT TISSUE CALCIFICATION; TIBIA FRACTURE; TUBERCULOUS PERITONITIS; WOUND CLOSURE; ADULT; BONE NAIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; SURGICAL INFECTION;

ADULT; BONE MORPHOGENETIC PROTEINS; BONE NAILS; FEMALE; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURE HEALING; FRACTURES, OPEN; HUMANS; MALE; RECOMBINANT PROTEINS; SINGLE-BLIND METHOD; SURGICAL WOUND INFECTION; TIBIAL FRACTURES; TRANSFORMING GROWTH FACTOR BETA;

EID: 79959579500     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.I.01763     Document Type: Article

References (24)

1. Anglen JO, Blue JM. A comparison of reamed and unreamed nailing of the tibia. J Trauma. 1995;39:351-5.
2. Court-Brown CM, Will E, Christie J, McQueen MM. Reamed or unreamed nailing for closed tibial fractures. A prospective study in Tscherne C1 fractures. J Bone Joint Surg Br. 1996;78:580-3. (Pubitemid 26241758)
3. Forster MC, Bruce AS, Aster AS. Should the tibia be reamed when nailing? Injury. 2005;36:439-44. (Pubitemid 40248400)
4. Bhandari M, Guyatt GH, Tong D, Adili A, Shaughnessy SG. Reamed versus non-reamed intramedullary nailing of lower extremity long bone fractures: a systematic overview and meta-analysis. J Orthop Trauma. 2000;14:2-9.
5. Gómez-Benito MJ, Fornells P, García-Aznar JM, Seral B, Seral-Iñnigo F, Doblaré M. Computational comparison of reamed versus unreamed intramedullary tibial nails. J Orthop Res. 2007;25:191-200. (Pubitemid 46344245)
6. Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures Investigators, Bhandari M, Guyatt G, Tornetta P 3rd, Schemitsch EH, Swiontkowski M, Sanders D, Walter SD. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am. 2008;90:2567-78.
7. Bhandari M, Guyatt GH, Swiontkowski MF, Schemitsch EH. Treatment of open fractures of the shaft of the tibia. J Bone Joint Surg Br. 2001;83:62-8. (Pubitemid 32170963)
8. Finkemeier CG, Schmidt AH, Kyle RF, Templeman DC, Varecka TF. A prospective, randomized study of intramedullary nails inserted with and without reaming for the treatment of open and closed fractures of the tibial shaft. J Orthop Trauma. 2000;14:187-93.
9. Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A. 2008;15:1311-20.
10. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res. 1999;14:1522-35. (Pubitemid 29416678)
11. Ji X, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T. Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab. 2000;18:132-9. (Pubitemid 30241107)
12. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976). 2000;25:376-81.
13. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent. 1997;17:11-25. (Pubitemid 127499619)
14. Burkus JK, Dorchak JD, Sanders DL. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine (Phila Pa 1976). 2003;28:372-7.
15. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123-34. (Pubitemid 35417689)
16. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A; BMP-2 Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study Group. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431-41.
17. Wozney JM. Biology and clinical applications of rhBMP-2. In: Lynch SE, Genco RJ, Marx RE, editors. Tissue engineering: applications in maxillofacial surgery and periodontics. Chicago: Quintessence; 1999. p 103-23.
18. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002;30:816-22. (Pubitemid 34616007)
19. Food and Drug Administration, Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research. Guidance for Industry. http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/default.htm. Accessed 2010 Feb 7.
20. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58:453-8.
21. Harris I, Lyons M. Reoperation rate in diaphyseal tibia fractures. ANZ J Surg. 2005;75:1041-4. (Pubitemid 43951361)
22. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J. 2004;4:527-39.
23. Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J. The human immune response to reconstituted bovine collagen. J Immunol. 1986;136:877-82. (Pubitemid 16146369)
24. Frank DH, Vakassian L, Fisher JC, Ozkan N. Human antibody response following multiple injections of bovine collagen. Plast Reconstr Surg. 1991;87:1080-8.